A Sympathetic Treatment for Obesity.

Related Articles

A Sympathetic Treatment for Obesity.

Cell Metab. 2020 Jun 02;31(6):1043-1045

Authors: Kim JD, Diano S

Abstract
Amphetamine (AMPH), mainly used in the treatment of attention deficit hyperactivity disorder and narcolepsy, has weight loss properties, although with detrimental cardiovascular effects. In this issue, Mahú et al. (2020) describe the effect of a new derivative of AMPH, “PEGyAMPH,” a brain-spared anti-obesity drug that alters sympathetic activity without cardiovascular side effects.

PMID: 32492388 [PubMed – as supplied by publisher]

via https://www.ncbi.nlm.nih.gov/pubmed/32492388?dopt=Abstract